Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Apr, 26 2025
Sep, 6 2024
Mar, 26 2026
Oct, 1 2025
Jan, 31 2026